Half-year report · Q2
9218.TEDINET S100U88E
Period2024-01-01 → 2024-06-30
Filed2024-08-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥2.3bn | 2024-01-01 → 2024-06-30 | Cons. | Net sales |
| Revenue | ¥2.6bn | 2023-01-01 → 2023-12-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥1.3bn | 2023-01-01 → 2023-06-30 | Cons. | Net sales |
| Operating income | −¥96m | 2024-01-01 → 2024-06-30 | Cons. | Operating income |
| Operating income | ¥217m | 2023-01-01 → 2023-06-30 | Cons. | Operating income |
| Ordinary income | −¥147m | 2024-01-01 → 2024-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥496m | 2023-01-01 → 2023-12-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥213m | 2023-01-01 → 2023-06-30 | Cons. | Ordinary income |
| Profit before tax | −¥146m | 2024-01-01 → 2024-06-30 | Cons. | Income before income taxes |
| Profit before tax | ¥219m | 2023-01-01 → 2023-06-30 | Cons. | Income before income taxes |
| Net income (owners) | −¥202m | 2024-01-01 → 2024-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥441m | 2023-01-01 → 2023-12-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥158m | 2023-01-01 → 2023-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | −¥202m | 2024-01-01 → 2024-06-30 | Cons. | Profit loss |
| Net income | ¥158m | 2023-01-01 → 2023-06-30 | Cons. | Profit loss |
| Total assets | ¥4.3bn | at 2024-06-30 | Cons. | Assets |
| Total assets | ¥1.7bn | at 2023-12-31 | Cons. | Assets |
| Total assets | ¥1.5bn | at 2023-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥3.2bn | at 2024-06-30 | Cons. | Liabilities |
| Total liabilities | ¥618m | at 2023-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥1.1bn | at 2024-06-30 | Cons. | Net assets |
| Net assets / equity | ¥1.1bn | at 2023-12-31 | Cons. | Net assets |
| Net assets / equity | ¥823m | at 2023-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥1.1bn | at 2024-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥914m | at 2023-12-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥1.1bn | at 2024-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥914m | at 2023-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥812m | at 2023-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥660m | at 2022-12-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥29m | 2024-01-01 → 2024-06-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥178m | 2023-01-01 → 2023-12-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥18m | 2023-01-01 → 2023-06-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥1.9bn | 2024-01-01 → 2024-06-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥91m | 2023-01-01 → 2023-12-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥38m | 2023-01-01 → 2023-06-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥2.1bn | 2024-01-01 → 2024-06-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥167m | 2023-01-01 → 2023-12-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥209m | 2023-01-01 → 2023-06-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥-20 | 2024-01-01 → 2024-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥44.29 | 2023-01-01 → 2023-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥16 | 2023-01-01 → 2023-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥41.78 | 2023-01-01 → 2023-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥14.96 | 2023-01-01 → 2023-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 21.4% | at 2024-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 64.3% | at 2023-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 56.6% | at 2023-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 39
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2024-01-01 → 2024-06-30 | −¥26m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-01-01 → 2024-06-30 | −¥26m |
| Reconciling Itemsreconciling | segment profit | 2024-01-01 → 2024-06-30 | −¥572m |
| jpcrp040300-q2r_E37508-000Digital Marketing Businessreportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥52m |
| jpcrp040300-q2r_E37508-000Digital Marketing Businessreportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥27m |
| jpcrp040300-q2r_E37508-000Digital Marketing Businessreportable segment | revenue intersegment | 2024-01-01 → 2024-06-30 | ¥25m |
| jpcrp040300-q2r_E37508-000Digital Marketing Businessreportable segment | segment profit | 2024-01-01 → 2024-06-30 | ¥11m |
| jpcrp040300-q2r_E37508-000Medical Career Support Businessreportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥84m |
| jpcrp040300-q2r_E37508-000Medical Career Support Businessreportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥84m |
| jpcrp040300-q2r_E37508-000Medical Career Support Businessreportable segment | segment profit | 2024-01-01 → 2024-06-30 | ¥26m |
| jpcrp040300-q2r_E37508-000Medical Work Shift Businessreportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥939m |
| jpcrp040300-q2r_E37508-000Medical Work Shift Businessreportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥939m |
| jpcrp040300-q2r_E37508-000Medical Work Shift Businessreportable segment | segment profit | 2024-01-01 → 2024-06-30 | ¥109m |
| jpcrp040300-q2r_E37508-000Mental Health Solution Businessreportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥1.2bn |
| jpcrp040300-q2r_E37508-000Mental Health Solution Businessreportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥1.2bn |
| jpcrp040300-q2r_E37508-000Mental Health Solution Businessreportable segment | revenue intersegment | 2024-01-01 → 2024-06-30 | ¥350,000 |
| jpcrp040300-q2r_E37508-000Mental Health Solution Businessreportable segment | segment profit | 2024-01-01 → 2024-06-30 | ¥330m |
| —segment total | revenue | 2024-01-01 → 2024-06-30 | ¥2.3bn |
| —segment total | revenue external | 2024-01-01 → 2024-06-30 | ¥2.3bn |
| —segment total | revenue intersegment | 2024-01-01 → 2024-06-30 | ¥26m |
| —segment total | segment profit | 2024-01-01 → 2024-06-30 | ¥476m |
| Reconciling Itemsreconciling | revenue | 2023-01-01 → 2023-06-30 | −¥53m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-01-01 → 2023-06-30 | −¥53m |
| Reconciling Itemsreconciling | segment profit | 2023-01-01 → 2023-06-30 | −¥153m |
| jpcrp040300-q2r_E37508-000Digital Marketing Businessreportable segment | revenue | 2023-01-01 → 2023-06-30 | ¥84m |
| jpcrp040300-q2r_E37508-000Digital Marketing Businessreportable segment | revenue external | 2023-01-01 → 2023-06-30 | ¥31m |
| jpcrp040300-q2r_E37508-000Digital Marketing Businessreportable segment | revenue intersegment | 2023-01-01 → 2023-06-30 | ¥52m |
| jpcrp040300-q2r_E37508-000Digital Marketing Businessreportable segment | segment profit | 2023-01-01 → 2023-06-30 | ¥36m |
| jpcrp040300-q2r_E37508-000Medical Career Support Businessreportable segment | revenue | 2023-01-01 → 2023-06-30 | ¥242m |
| jpcrp040300-q2r_E37508-000Medical Career Support Businessreportable segment | revenue external | 2023-01-01 → 2023-06-30 | ¥242m |
| jpcrp040300-q2r_E37508-000Medical Career Support Businessreportable segment | segment profit | 2023-01-01 → 2023-06-30 | ¥135m |
| jpcrp040300-q2r_E37508-000Mental Health Solution Businessreportable segment | revenue | 2023-01-01 → 2023-06-30 | ¥1.0bn |
| jpcrp040300-q2r_E37508-000Mental Health Solution Businessreportable segment | revenue external | 2023-01-01 → 2023-06-30 | ¥1.0bn |
| jpcrp040300-q2r_E37508-000Mental Health Solution Businessreportable segment | revenue intersegment | 2023-01-01 → 2023-06-30 | ¥450,000 |
| jpcrp040300-q2r_E37508-000Mental Health Solution Businessreportable segment | segment profit | 2023-01-01 → 2023-06-30 | ¥198m |
| —segment total | revenue | 2023-01-01 → 2023-06-30 | ¥1.4bn |
| —segment total | revenue external | 2023-01-01 → 2023-06-30 | ¥1.3bn |
| —segment total | revenue intersegment | 2023-01-01 → 2023-06-30 | ¥53m |
| —segment total | segment profit | 2023-01-01 → 2023-06-30 | ¥369m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 520
| Item | Context | Value | Unit |
|---|---|---|---|
| Net sales | CurrentYTDDuration_ReportableSegmentsMember | 2301511000 | JPY |
| Net sales | CurrentYTDDuration_ReconcilingItemsMember | -25699000 | JPY |
| Net sales | CurrentYTDDuration | 2275812000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q2r_E37508-000MentalHealthSolutionBusinessReportableSegmentsMember | 329944000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q2r_E37508-000MedicalWorkShiftBusinessReportableSegmentsMember | 108742000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q2r_E37508-000MedicalCareerSupportBusinessReportableSegmentsMember | 25707000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q2r_E37508-000DigitalMarketingBusinessReportableSegmentsMember | 11368000 | JPY |
| Operating income | CurrentYTDDuration_ReportableSegmentsMember | 475762000 | JPY |
| Operating income | CurrentYTDDuration_ReconcilingItemsMember | -572046000 | JPY |
| Operating income | CurrentYTDDuration | -96283000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)半期報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条の５第１項の表の第１号 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)関東財務局長 | |
| Filing date cover page | FilingDateInstant | 2024-08-14 | |
| Quarterly accounting period cover page | FilingDateInstant | Original text (Japanese)第14期中（自2024年１月１日 至2024年６月30日） | |
| Company name cover page | FilingDateInstant | Original text (Japanese)株式会社メンタルヘルステクノロジーズ | |
| Company name in english cover page | FilingDateInstant | Mental Health Technologies Co.,Ltd. | |
| Title and name of representative cover page | FilingDateInstant | Original text (Japanese)代表取締役社長 刀禰 真之介 | |
| Address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)東京都港区赤坂３－16－11 東海赤坂ビル４階 | |
| Telephone number address of registered headquarter cover page | FilingDateInstant | 03（6277）6595 | |
| Name of contact person address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)取締役事業開発・Ｍ＆Ａ室室長兼コーポレート本部担当 松浦 優 | |
| Nearest place of contact cover page | FilingDateInstant | Original text (Japanese)東京都港区赤坂３－16－11 東海赤坂ビル４階 | |
| Telephone number nearest place of contact cover page | FilingDateInstant | 03（6277）6595 | |
| Name of contact person nearest place of contact cover page | FilingDateInstant | Original text (Japanese)取締役事業開発・Ｍ＆Ａ室室長兼コーポレート本部担当 松浦 優 | |
| Place for public inspection cover page (text) | FilingDateInstant | Text · Plus | |
| Edinet code | FilingDateInstant | E37508 | |
| Fund code | FilingDateInstant | － | |
| Security code | FilingDateInstant | 92180 | |
| Filer name in japanese | FilingDateInstant | Original text (Japanese)株式会社メンタルヘルステクノロジーズ | |
| Filer name in english | FilingDateInstant | Mental Health Technologies Co.,Ltd. | |
| Fund name in japanese | FilingDateInstant | － | |
| Fund name in english | FilingDateInstant | － | |
| Cabinet office ordinance | FilingDateInstant | Original text (Japanese)企業内容等の開示に関する内閣府令 | |
| Document type | FilingDateInstant | Original text (Japanese)第四号の三様式 | |
| Accounting standards | FilingDateInstant | Japan GAAP | |
| Whether consolidated financial statements are prepared | FilingDateInstant | true | |
| Industry code when consolidated financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | CTE | |
| Industry code when financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | － | |
| Current fiscal year start date | FilingDateInstant | 2024-01-01 | |
| Current period end date | FilingDateInstant | 2024-06-30 | |
| Type of current period | FilingDateInstant | Q2 | |
| Current fiscal year end date | FilingDateInstant | 2024-12-31 | |
| Previous fiscal year start date | FilingDateInstant | 2023-01-01 | |
| Comparative period end date | FilingDateInstant | 2023-06-30 | |
| Previous fiscal year end date | FilingDateInstant | 2023-12-31 | |
| Next fiscal year start date | FilingDateInstant | － | |
| End date of quarterly or semi annual period of next fiscal year | FilingDateInstant | － | |
| Amendment flag | FilingDateInstant | false | |
| Identification of document subject to amendment | FilingDateInstant | － | |
| Report amendment flag | FilingDateInstant | false |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |